Elting, Jan-Willem <br/><br/>
AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.  [electronic resource] 

 -  Stroke  Dec 2002 
 - 2813-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4628 
<br/><br/><label>Standard No.: </label>10.1161/01.str.0000043823.37955.fb  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Aged<br/>Area Under Curve<br/>Biomarkers--blood<br/>Brain Ischemia--blood<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Excitatory Amino Acid Antagonists--adverse effects<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Nerve Growth Factors--blood<br/>Neuroglia--drug effects<br/>Organophosphonates--adverse effects<br/>Phosphopyruvate Hydratase--blood<br/>Quinoxalines--adverse effects<br/>Receptors, AMPA--antagonists & inhibitors<br/>Regression Analysis<br/>S100 Calcium Binding Protein beta Subunit<br/>S100 Proteins--blood<br/>Severity of Illness Index<br/>Stroke--blood<br/>Treatment Outcome